1. Home
  2. |Insights
  3. |Janssen Biotech Unable To Rewrite History and Save Remicade Patent

Janssen Biotech Unable To Rewrite History and Save Remicade Patent

Client Alert | less than 1 min read | 01.25.18

Insights

Client Alert | 5 min read | 07.21.26

Last Call: “FAR CUI Rule” Draft Language Provides an Opportunity for Contractors to Weigh in by this Week

The FAR Council recently released an updated draft of the much-anticipated “FAR CUI Rule” that would apply to contractors government-wide....